PL2529748T3 - Szczepionka - Google Patents

Szczepionka

Info

Publication number: PL2529748T3
Authority: PL; Poland
Prior art keywords: vaccine
Prior art date: 2009-07-23

Application number

PL12182229T

Other languages

English (en)

Inventor

Günther Staffler

Petra Lührs

Andrea Dolischka

Andreas Mairhofer

Frank Mattner

Walter Schmidt

Original Assignee

Affiris Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-07-23

Filing date

2010-07-23

Publication date

2015-12-31

2010-07-23 Application filed by Affiris Ag filed Critical Affiris Ag

2015-12-31 Publication of PL2529748T3 publication Critical patent/PL2529748T3/pl

Links

229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Toxicology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Neurology (AREA)
Hematology (AREA)
Diabetes (AREA)
Transplantation (AREA)
Neurosurgery (AREA)

PL12182229T 2009-07-23 2010-07-23 Szczepionka PL2529748T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AT0116209A AT508569A1 (de)	2009-07-23	2009-07-23	Pharmaceutical compound
EP12182229.0A EP2529748B1 (en)	2009-07-23	2010-07-23	Vaccine
EP10747785A EP2456459A1 (en)	2009-07-23	2010-07-23	Vaccine

Publications (1)

Publication Number	Publication Date
PL2529748T3 true PL2529748T3 (pl)	2015-12-31

Family

ID=42830427

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12182229T PL2529748T3 (pl)	2009-07-23	2010-07-23	Szczepionka

Country Status (18)

Country	Link
US (2)	US9029327B2 (pl)
EP (3)	EP2456459A1 (pl)
JP (2)	JP5785542B2 (pl)
KR (1)	KR20120052348A (pl)
CN (1)	CN102573894A (pl)
AR (1)	AR077423A1 (pl)
AT (1)	AT508569A1 (pl)
AU (1)	AU2010276069B2 (pl)
BR (1)	BR112012001521A2 (pl)
CA (1)	CA2767187A1 (pl)
DK (1)	DK2529748T3 (pl)
ES (1)	ES2541754T3 (pl)
IL (1)	IL217194A0 (pl)
MX (1)	MX2012000813A (pl)
PL (1)	PL2529748T3 (pl)
PT (1)	PT2529748E (pl)
RU (2)	RU2534883C2 (pl)
WO (1)	WO2011009152A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2795329A2 (en) *	2011-12-23	2014-10-29	Medical Research Council	Selective ligands for the angiotensin ii receptors
CA3003943A1 (en)	2015-11-03	2017-05-11	Affiris Ag	Method for vaccination against a self-antigen in a human patient

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU177133B (en) *	1977-07-18	1981-07-28	Richter Gedeon Vegyeszet	Process for preparing angiotensin ii analogues containing alpha- amino-oxy-acid in position 1 with angiotensin ii antagonist activity
WO1996040755A1 (en)	1995-06-07	1996-12-19	Dlo Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo)	An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine
WO1999040107A2 (en) *	1998-02-09	1999-08-12	University Of Southern California	Method of promoting keratinocyte proliferation
ATE250423T1 (de) *	1998-07-13	2003-10-15	Univ Southern California	Verfahren zur beschleunigen den zuwachs und heilen von knochen und knorpel
AU755943B2 (en) *	1998-08-13	2003-01-02	University Of Southern California	Methods to increase blood flow to ischemic tissue
US20090175821A1 (en) *	1999-05-17	2009-07-09	Bridon Dominique P	Modified therapeutic peptides with extended half-lives in vivo
EP1239867B1 (en) *	1999-12-16	2005-01-26	University of Southern California	Methods for treating and preventing damage to mucosal tissue
WO2001055176A2 (en) *	2000-01-27	2001-08-02	University Of Southern California	Methods for inhibiting smooth muscle cell proliferation
WO2001098325A1 (en) *	2000-06-19	2001-12-27	University Of Southern California	Methods for treating and preventing alopecia
US20020165141A1 (en) *	2000-07-13	2002-11-07	Dizerega Gere S.	Methods for promoting dendritic cell proliferation or differentiation
CA2416538A1 (en) *	2000-07-20	2002-01-31	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2002308522A1 (en) *	2001-05-01	2002-11-11	University Of Southern California	Methods for inhibiting tumor cell proliferation
AUPR593101A0 (en)	2001-06-26	2001-07-19	Council Of The Queensland Institute Of Medical Research, The	Cytomegalovirus t cell epitopes
US7115266B2 (en) *	2001-10-05	2006-10-03	Cytos Biotechnology Ag	Angiotensin peptide-carrier conjugates and uses thereof
RU2350622C2 (ru) *	2001-10-05	2009-03-27	Цитос Байотекнолоджи Аг	Конъюгат ангиотензиновой пептидной составляющей с носителем, композиция вакцины, способ иммунизации животного и способ лечения или профилактики физического нарушения, ассоциированного с активируемой ренином ангиотензиновой системой
EP1444254A2 (en) *	2001-10-12	2004-08-11	Incyte Genomics, Inc.	Molecules for disease detection and treatment
US20050074865A1 (en)	2002-08-27	2005-04-07	Compound Therapeutics, Inc.	Adzymes and uses thereof
ATE442378T1 (de) *	2002-09-20	2009-09-15	Int Inst Cancer Immunology Inc	Substituierte wt1-peptide
WO2005019258A2 (en) *	2003-08-11	2005-03-03	Genentech, Inc.	Compositions and methods for the treatment of immune related diseases
US7785566B2 (en) *	2003-11-06	2010-08-31	Ge Healthcare, Inc.	Pharmaceutical compounds
RU2259847C1 (ru) *	2004-08-12	2005-09-10	Ветошкин Владимир Геннадьевич	Вакцина против гипертонии
WO2009023714A2 (en) *	2007-08-14	2009-02-19	Thymon, Llc	Compositions and methods for the treatment and prophylaxis of hypertension

2009
- 2009-07-23 AT AT0116209A patent/AT508569A1/de not_active Application Discontinuation
2010
- 2010-07-23 PT PT121822290T patent/PT2529748E/pt unknown
- 2010-07-23 ES ES12182229.0T patent/ES2541754T3/es active Active
- 2010-07-23 PL PL12182229T patent/PL2529748T3/pl unknown
- 2010-07-23 DK DK12182229.0T patent/DK2529748T3/en active
- 2010-07-23 RU RU2012106506/10A patent/RU2534883C2/ru not_active IP Right Cessation
- 2010-07-23 KR KR1020127004797A patent/KR20120052348A/ko not_active Ceased
- 2010-07-23 BR BR112012001521A patent/BR112012001521A2/pt not_active IP Right Cessation
- 2010-07-23 EP EP10747785A patent/EP2456459A1/en not_active Withdrawn
- 2010-07-23 AU AU2010276069A patent/AU2010276069B2/en not_active Ceased
- 2010-07-23 US US13/386,603 patent/US9029327B2/en not_active Expired - Fee Related
- 2010-07-23 JP JP2012520860A patent/JP5785542B2/ja not_active Expired - Fee Related
- 2010-07-23 WO PCT/AT2010/000271 patent/WO2011009152A1/en not_active Ceased
- 2010-07-23 CN CN201080042649XA patent/CN102573894A/zh active Pending
- 2010-07-23 MX MX2012000813A patent/MX2012000813A/es active IP Right Grant
- 2010-07-23 EP EP13175730.4A patent/EP2671592A3/en not_active Ceased
- 2010-07-23 AR ARP100102684A patent/AR077423A1/es unknown
- 2010-07-23 EP EP12182229.0A patent/EP2529748B1/en active Active
- 2010-07-23 CA CA2767187A patent/CA2767187A1/en not_active Abandoned
2011
- 2011-12-25 IL IL217194A patent/IL217194A0/en unknown
2014
- 2014-03-04 US US14/196,511 patent/US20140255435A1/en not_active Abandoned
- 2014-04-22 RU RU2014116169/10A patent/RU2014116169A/ru not_active Application Discontinuation
2015
- 2015-06-04 JP JP2015114201A patent/JP2015214552A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
EP2529748A3 (en)	2013-01-09
RU2012106506A (ru)	2013-08-27
JP2015214552A (ja)	2015-12-03
CA2767187A1 (en)	2011-01-27
PT2529748E (pt)	2015-09-24
IL217194A0 (en)	2012-02-29
EP2671592A2 (en)	2013-12-11
EP2671592A3 (en)	2014-04-23
EP2456459A1 (en)	2012-05-30
AU2010276069A1 (en)	2012-02-02
US20140255435A1 (en)	2014-09-11
KR20120052348A (ko)	2012-05-23
EP2529748B1 (en)	2015-04-22
US20120269836A1 (en)	2012-10-25
RU2014116169A (ru)	2015-10-27
RU2534883C2 (ru)	2014-12-10
MX2012000813A (es)	2012-02-28
JP2012533572A (ja)	2012-12-27
AT508569A1 (de)	2011-02-15
WO2011009152A1 (en)	2011-01-27
AR077423A1 (es)	2011-08-24
JP5785542B2 (ja)	2015-09-30
ES2541754T3 (es)	2015-07-24
CN102573894A (zh)	2012-07-11
BR112012001521A2 (pt)	2017-05-02
DK2529748T3 (en)	2015-07-06
US9029327B2 (en)	2015-05-12
AU2010276069B2 (en)	2014-11-06
EP2529748A2 (en)	2012-12-05

Publication	Publication Date	Title
ZA201109164B (en)	2012-09-26	Vaccine
GB0905570D0 (en)	2009-05-13	Combined vaccines
ZA201101481B (en)	2012-07-25	Vaccine
ZA201007331B (en)	2014-03-26	Vaccine
GB0822001D0 (en)	2009-01-07	Vaccine
GB201006165D0 (en)	2010-05-26	Vaccine
GB0810710D0 (en)	2008-07-16	Vaccine
ZA201007402B (en)	2014-03-26	Vaccine
GB201014965D0 (en)	2010-10-20	Vaccine
GB0816447D0 (en)	2008-10-15	Vaccine
GB0816284D0 (en)	2008-10-15	Vaccine
GB0907935D0 (en)	2009-06-24	Vaccines
IL216102A0 (en)	2012-01-31	Combined measles-malaria vaccine
GB201000522D0 (en)	2010-03-03	Vaccine
GB201013006D0 (en)	2010-09-15	Vaccine
GB201006324D0 (en)	2010-06-02	Vaccine
IL217194A0 (en)	2012-02-29	Vaccine
IL225413A0 (en)	2013-06-27	Vaccination
GB0914545D0 (en)	2009-09-30	Vaccine
ZA201107971B (en)	2012-07-25	Combined measles-malaria vaccine
GB0909146D0 (en)	2009-07-01	Vaccines
GB0909144D0 (en)	2009-07-01	Vaccines
GB0909145D0 (en)	2009-07-01	Vaccines
GB0909147D0 (en)	2009-07-01	Vaccines
GB0810215D0 (en)	2008-07-09	Vaccine